Your browser doesn't support javascript.
loading
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.
Sankaranarayanan, Rengaswamy; Joshi, Smita; Muwonge, Richard; Esmy, Pulikottil Okkuru; Basu, Partha; Prabhu, Priya; Bhatla, Neerja; Nene, Bhagwan M; Shaw, Janmesh; Poli, Usha Rani Reddy; Verma, Yogesh; Zomawia, Eric; Pimple, Sharmila; Tommasino, Massimo; Pawlita, Michael; Gheit, Tarik; Waterboer, Tim; Sehr, Peter; Pillai, Madhavan Radhakrishna.
Afiliação
  • Sankaranarayanan R; Screening Group, International Agency for Research on Cancer, Lyon, France. Electronic address: sankarr@iarc.fr.
  • Joshi S; Jehangir Clinical Development Centre, Jehangir Hospital, Pune, India.
  • Muwonge R; Screening Group, International Agency for Research on Cancer, Lyon, France.
  • Esmy PO; Christian Fellowship Community Health Centre, Ambillikai, India.
  • Basu P; Screening Group, International Agency for Research on Cancer, Lyon, France.
  • Prabhu P; Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, India.
  • Bhatla N; All India Institute of Medical Sciences, New Delhi, India.
  • Nene BM; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Barshi, Solapur District, Maharashtra, India.
  • Shaw J; Gujarat Cancer and Research Institute, MP Shaw Cancer Hospital, Ahmedabad, India.
  • Poli URR; Mehdi Nawaj Jung Institute of Oncology and Regional Cancer Center, Red Hills, Lakadikapul, Hyderabad, Andhra Pradesh, India.
  • Verma Y; Sikkim Manipal Institute of Medical Sciences, Gangtok, Sikkim, India.
  • Zomawia E; Civil Hospital, Aizawl, Mizoram, India.
  • Pimple S; Department of Preventive Oncology, Tata Memorial Centre, Parel, Mumbai, India.
  • Tommasino M; Infections and Cancer Biology Group, Infections Section, International Agency for Research on Cancer, Lyon, France.
  • Pawlita M; Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany.
  • Gheit T; Infections and Cancer Biology Group, Infections Section, International Agency for Research on Cancer, Lyon, France.
  • Waterboer T; Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany.
  • Sehr P; EMBL-DKFZ Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Pillai MR; Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, India.
Vaccine ; 36(32 Pt A): 4783-4791, 2018 08 06.
Article em En | MEDLINE | ID: mdl-29551226

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2018 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus / Papillomavirus Humano 16 / Papillomavirus Humano 18 / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2018 Tipo de documento: Article País de publicação: Holanda